Learn More
Medchemexpress LLC Dx3-213b | 2749555-66-4 | 99.7% | 478.57 g/mol | C20H28F2N2O5S2 | 5 MG

Supplier: Medchemexpress LLC HY1443105MG
DX3-213B is a potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor used in preclinical research. It disrupts mitochondrial ATP production and exhibits cellular activity in cancer models, making it useful for mechanistic studies of mitochondrial function and cancer metabolism. Not for human use.
- Highly potent complex I inhibition (IC50 = 3.6 nM)
- Impairs ATP generation in cells (IC50 = 11 nM)
- Inhibits growth of pancreatic cancer cell line (GI50 = 11 nM)
- High chemical purity suitable for biochemical assays
- Available as solid and DMSO solution for assay flexibility
- Intended for mechanistic mitochondrial and cancer metabolism research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.